In this poster, we report on new insights about mechanisms of sensitivity and resistance to EGFR inhibitors like cetuximab and afatinib, both of which are currently in clinical trials.
AACR 2023: Mechanisms of EGFR inhibitor sensitivity and resistance in chordoma
- The path to cures
- Publications
- AACR 2023: Mechanisms of EGFR inhibitor sensitivity and resistance in chordoma